Welcome! You are invited to join a meeting: National CM Community of Practice (CoP). After registering, you will receive a confirmation email about joining the meeting.

Lara Coughlin’s research on substance use disorders and addiction care informs policy and practice at the local, state, and national levels.

Welcome! You are invited to join a meeting: National CM Community of Practice (CoP). After registering, you will receive a confirmation email about joining the meeting.

Welcome! You are invited to join a meeting: National CM Community of Practice (CoP). After registering, you will receive a confirmation email about joining the meeting.

The pJITAI is promising among not-in-treatment emerging adults, with messages increasing engagement, warranting further refinement to optimize this intervention.

Over a 9-year period, Hendricks and colleagues1 piloted psilocybin-assisted therapy for cocaine use disorder (CUD) among 40 adults. Results supported the treatment for improving cocaine-related outcom...

It was a shower of affection at Greater Grace Temple this afternoon. New moms and pregnant women were able to take part in a community baby shower during Black Maternal Health Week.

YouTube video by Contingency Management Innovations

YouTube video by American Psychological Association

41% drop in risk of death seen in veterans who got incentives to stick with recovery from using stimulants like methamphetamine and cocaine, compared with those who didn’t

New federal dietary guidelines announced this week are a sharp departure from previous such guidelines, including a specific focus on processed foods, an emphasis on red meat and full-fat dairy, and a...

Addiction remains one of the most pressing health challenges. Across the world, researchers are advancing how we address substance use disorders by understanding risk factors and patterns of use, diag...

Among people over 50 who use cannabis, those most likely to drive after partaking are men, people who use daily, and those who use THC-containing products for mental health reasons

Introduction Polysubstance use (PSU), particularly opioid-involved and stimulant-involved PSU, is a growing issue in the USA. PSU increases the risk of negative health consequences, including infectio...

PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.

PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.

PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.

Talking to patients about tobacco cessation can be difficult, join us virtually and become more confident! Join us in November as we provide resources for clinicians to become more confident talking t...

Scooter riders may soon need to prove they’re sober before going for a late-night ride, after the Ann Arbor City Council approved a new contract with Spin.

Introduction Substance use disorders (SUDs) are a prevalent issue in the United States (U.S.) and there is a need for innovative treatments to address this public health issue. As of March 2025, there are seven states either approved or in the process of applying for Sect. 1115 Demonstration Waivers to implement pilot contingency management (CM) programs for SUD treatment. This manuscript qualitatively summarizes these Sect. 1115 Demonstration Waivers and the different aspects of each U.S. state's program. Methods Data are from states Sect. 1115 Demonstration Waivers, collected through September 2024 and updated in March 2025. When possible the information has been verified with pilot program managers from each state, and pilot program managers have provided information when possible. Results Eight states have applied for Sect. 1115 Demonstration Waivers to implement pilot CM programs. Five states have been approved (California, Washington, Montana, Hawaii, and Delaware), two are pending approval (Michigan, and Rhode Island) and one state’s CM application was denied (West Virginia). California is the only state to have confirmed implementing the Sect. 1115 Demonstration Waiver funding and has started to review evaluation data. The CM programs covered under Sect. 1115 Demonstration Waivers vary in substance targeted (e.g., stimulants, opioids), length of program (12–64 weeks), amount of incentives ($596–1092), and other characteristics (e.g. incentive delivery type, schedule of reinforcement). Conclusions Section 1115 Demonstration Waivers addressing SUDs with CM are still new but with the increase in waivers approved, states who wish to apply and receive funding can learn from the approved waivers.

Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study American Journal of Psychiatry This national retrospective cohort study found that veterans with stimul...

You are invited to join us for an exclusive look at the Peterson Health Technology Institute's (PHTI) latest assessment of virtual opioid use disorder (OUD) solutions. We will share our findings on th...

41% drop in risk of death seen in veterans who got incentives to stick with recovery from using stimulants like methamphetamine and cocaine, compared with those who didn’t

Background: Remote recruitment for human participant research is increasingly popular due to its speed, cost-effectiveness, and accessibility for participants. However, in some cases, it can be partic...

While AHSR 2025 may be on pause, our community isn’t! Join us for a special six-part webinar series running through Fall 2025 and Spring 2026 as we stay connected and dive into the most pressing topic...

Cannabis in Practice is a virtual web series for healthcare providers. Featuring multiple speakers on multiple topics.